Literature DB >> 2277713

The role of descending noradrenergic systems in regulation of nociception: the effects of intrathecally administered alpha-adrenoceptor antagonists and clonidine.

Arne Tjølsen1, Anders Lund, Kjell Hole.   

Abstract

It has been proposed that descending noradrenergic systems exercise a tonic inhibition of nociception at the spinal level. The recent finding that changes in tail skin temperature (TT) may have a strong effect on the tail-flick latency makes a reevaluation of this hypothesis necessary. The alpha-adrenoceptor agonist clonidine injected intrathecally (i.th.) in a dose of 60 micrograms increased the response temperature in the increasing hot plate test 10 min after injection, and prolonged the tail-flick latency 30-60 min after injection. A considerable part of the change in tail-flick latency was caused by a reduction in TT. The alpha 1-antagonist prazosin (30 and 60 micrograms) tended to increase the response temperature in the increasing hot plate test after 60 min, and to prolong the latency in the tail-flick test. These effects were not statistically significant. Clonidine and prazosin induced sensorimotor impairment and a reduction in body temperature after 30-60 min. The alpha 2-antagonist yohimbine had no effect in the increasing hot plate test, but reduced the tail-flick latency 10 min after drug administration. This reduction could be explained by an increase in TT. The results suggest that the reduced latency in the tail-flick test after i.th. injection of yohimbine is caused by an increase in the tail blood flow, and does not support the hypothesis of a tonic bulbospinal noradrenergic inhibition of nociception. The time course of response latencies suggests that supraspinal mechanisms may be involved in the effects of i.th. clonidine and prazosin in the tail-flick test, while there seems to be a spinally mediated antinociceptive effect of clonidine that can be demonstrated in the increasing hot plate test.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2277713     DOI: 10.1016/0304-3959(90)90056-J

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  6 in total

1.  The Neurotoxin DSP-4 Induces Hyperalgesia in Rats that is Accompanied by Spinal Oxidative Stress and Cytokine Production.

Authors:  Jillienne C Touchette; Joshua W Little; Gerald H Wilken; Daniela Salvemini; Heather Macarthur
Journal:  Neuroscience       Date:  2018-02-05       Impact factor: 3.590

2.  Interaction between the antinociceptive effect of ketoprofen and adrenergic modulatory systems.

Authors:  G Pinardi; F Sierralta; H F Miranda
Journal:  Inflammation       Date:  2001-08       Impact factor: 4.092

3.  Opioid and noradrenergic contributions of tapentadol in experimental neuropathic pain.

Authors:  Diana S Meske; Jennifer Y Xie; Janice Oyarzo; Hamid Badghisi; Michael H Ossipov; Frank Porreca
Journal:  Neurosci Lett       Date:  2013-08-19       Impact factor: 3.046

4.  Lack of effect of microinjection of noradrenaline or medetomidine on stimulus-evoked release of substance P in the spinal cord of the cat: a study with antibody microprobes.

Authors:  C W Lang; P J Hope; B D Grubb; A W Duggan
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

5.  Pain relief by supraspinal gabapentin requires descending noradrenergic inhibitory controls.

Authors:  Dina L Juarez-Salinas; Joao M Braz; Katherine A Hamel; Allan I Basbaum
Journal:  Pain Rep       Date:  2018-07-17

Review 6.  Systematic Review of Systemic and Neuraxial Effects of Acetaminophen in Preclinical Models of Nociceptive Processing.

Authors:  Hiroshi Hoshijima; Matthew Hunt; Hiroshi Nagasaka; Tony Yaksh
Journal:  J Pain Res       Date:  2021-11-12       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.